1. Home
  2. CRIS vs GDHG Comparison

CRIS vs GDHG Comparison

Compare CRIS & GDHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRIS
  • GDHG
  • Stock Information
  • Founded
  • CRIS 2000
  • GDHG 2008
  • Country
  • CRIS United States
  • GDHG China
  • Employees
  • CRIS N/A
  • GDHG N/A
  • Industry
  • CRIS Biotechnology: Biological Products (No Diagnostic Substances)
  • GDHG Services-Misc. Amusement & Recreation
  • Sector
  • CRIS Health Care
  • GDHG Consumer Discretionary
  • Exchange
  • CRIS Nasdaq
  • GDHG Nasdaq
  • Market Cap
  • CRIS 18.6M
  • GDHG 19.4M
  • IPO Year
  • CRIS 2000
  • GDHG 2023
  • Fundamental
  • Price
  • CRIS $1.14
  • GDHG $4.28
  • Analyst Decision
  • CRIS Strong Buy
  • GDHG
  • Analyst Count
  • CRIS 2
  • GDHG 0
  • Target Price
  • CRIS $16.50
  • GDHG N/A
  • AVG Volume (30 Days)
  • CRIS 75.6K
  • GDHG 53.3K
  • Earning Date
  • CRIS 11-06-2025
  • GDHG 07-11-2025
  • Dividend Yield
  • CRIS N/A
  • GDHG N/A
  • EPS Growth
  • CRIS N/A
  • GDHG N/A
  • EPS
  • CRIS N/A
  • GDHG N/A
  • Revenue
  • CRIS $11,650,000.00
  • GDHG $16,666,899.00
  • Revenue This Year
  • CRIS $2.72
  • GDHG N/A
  • Revenue Next Year
  • CRIS $8.27
  • GDHG N/A
  • P/E Ratio
  • CRIS N/A
  • GDHG N/A
  • Revenue Growth
  • CRIS 13.56
  • GDHG N/A
  • 52 Week Low
  • CRIS $1.02
  • GDHG $2.40
  • 52 Week High
  • CRIS $4.70
  • GDHG $1,968.41
  • Technical
  • Relative Strength Index (RSI)
  • CRIS 20.03
  • GDHG 40.65
  • Support Level
  • CRIS $1.21
  • GDHG $3.96
  • Resistance Level
  • CRIS $1.35
  • GDHG $4.25
  • Average True Range (ATR)
  • CRIS 0.09
  • GDHG 0.28
  • MACD
  • CRIS -0.03
  • GDHG 0.07
  • Stochastic Oscillator
  • CRIS 1.92
  • GDHG 50.31

About CRIS Curis Inc.

Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

About GDHG Golden Heaven Group Holdings Ltd.

Golden Heaven Group Holdings Ltd is an offshore holding company. Through the operating entities in China, It manages and operates six properties consisting of amusement parks, water parks, and complementary recreational facilities. The parks offer a broad selection of exhilarating and recreational experiences, including both thrilling and family-friendly rides, water attractions, gourmet festivals, circus performances, and high-tech facilities. The parks collectively contain nearly 159 rides and attractions. The firm's revenue is generated from selling access to rides and attractions, charging fees for special event rentals, and collecting regular rental payments from commercial tenants.

Share on Social Networks: